Abnormal Glutamate Receptor Expression in the Medial Temporal Lobe in Schizophrenia and Mood Disorders
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Pharmacological and anatomical evidence suggests that abnormal glutamate neurotransmission may be associated with the pathophysiology of schizophrenia and mood disorders. Medial temporal lobe structural alterations have been implicated in schizophrenia and to a lesser extent in mood disorders. To comprehensively examine the ionotropic glutamate receptors in these illnesses, we used in situ hybridization to determine transcript expression of N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and kainate receptor subunits in the medial temporal lobe of subjects with schizophrenia, bipolar disorder (BD), or major depression (MDD). We used receptor autoradiography to assess changes in glutamate receptor binding in the same subjects. Our results indicate that there are region- and disorder-specific abnormalities in the expression of ionotropic glutamate receptor subunits in schizophrenia and mood disorders. We did not find any changes in transcript expression in the hippocampus. In the entorhinal cortex, most changes in glutamate receptor expression were associated with BD, with decreased GluR2, GluR3, and GluR6 mRNA expression. In the perirhinal cortex we detected decreased expression of GluR5 in all three diagnoses, of GluR1, GluR3, NR2B in both BD and MDD, and decreased NR1 and NR2A in BD and MDD, respectively. Receptor binding showed NMDA receptor subsites particularly affected in the hippocampus, where MK801 binding was reduced in schiz…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In depressed patients, synaptic plasticity pathways have been shown to be disrupted in the PFC and hippocampi, correlated with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptor abnormalities [45,46].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [45]
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 2×
“Neurotransmission mediated by ionotropic glutamate receptors underlies several forms of synaptic plasticity in the hippocampus, including long-term potentiation (LTP) and depression (LTD) (Bliss and Collingridge, 1993; Isaac et al, 1995; Linden and Connor, 1995; Nicoll and Malenka, 1995; Selig et al, 1995; Bear and Ab…”
BackgroundLOSS OF RECENT MEMORY AFTER BILATERAL HIPPOCAMPAL LESIONS
Scoville, W. B., & Milner, B. (1957) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.20.1.11 · Cited by 7,322
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 2×
“Scale bar: 5 mm. Neuropsychopharmacology containing predominantly NR2B to containing NR2A in response to different stimuli (Monyer et al, 1994; Sheng et al, 1994).”
BackgroundThe Medial Temporal Lobe Memory System
Squire, L. R., & Zola-Morgan, S. (1991) · Science · doi:10.1126/science.1896849 · Cited by 3,282 · cited 1×
“The entorhinal cortex is a crucial component of the medial temporal lobe memory system (Scoville and Milner, 1957; Squire and Zola-Morgan, 1991).”
BackgroundLong-Term Potentiation--A Decade of Progress?
Malenka, R. C., & Nicoll, A. R. A. (1999) · Science · doi:10.1126/science.285.5435.1870 · Cited by 2,729
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · cited 1×
“…in neuronal size, density, and localization in the hippocampus in schizophrenia and BD, and to a lesser extent in major depressive disorder (MDD) (Arnold, 1997; Benes et al, 1998, 1999; Harrison, 1999; Weinberger, 1999; Harrison and Eastwood, 2001; Heckers and Konradi, 2002; Rajkowska, 2002a, b).”
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
Cited by
Items 301–400 of 451
Foll, J. L., & Pelletier, A. (2009) · L Encéphale · doi:10.1016/j.encep.2009.06.008 · Cited by 10
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders
Gómez de San José, N., Goossens, J., Al Shweiki, M. R., Halbgebauer, S., Oeckl, P., Steinacker, P., Danzer, K. M., Graf, H., Schönfeldt-Lecuona, C., Belbin, O., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.010 · Cited by 9
Gardner, W., Sarrazin, D. H., Balzinger, M., Marchese, C., Ragno, A., Ramanathan, C., Veleanu, M., Vestring, S., Normann, C., Bourgin, P., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03276-7 · Cited by 9
Subsequent memory effects in schizophrenia
Collier, A. K., Wolf, D. H., Valdez, J. N., Gur, R. E., & Gur, R. C. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.10.012 · Cited by 9
Chen, J., Luo, Y., Liang, X., Kong, X., Xiao, Q., Tang, J., Qi, Y., Tang, Y. C., & Xiu, Y. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0255 · Cited by 9
Bao, H., Ran, P., Sun, L., Hu, W., Li, H., Xiao, C., Zhu, K., & Du, J. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1235590 · Cited by 9
Astrocytes in Bipolar Disorder
Butt, A. M., & Rivera, A. D. (2021) · Advances in neurobiology · doi:10.1007/978-3-030-77375-5_5 · Cited by 9
Ortuño, F., & Gutiérrez-Rojasb, L. (2011) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(11)70159-7 · Cited by 9
Duncan, G. E., Koller, B. H., & Moy, S. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.009 · Cited by 9
Identification of genetic modifiers of murine hepatic β-glucocerebrosidase activity
Durán, A., Rebolledo‐Jaramillo, B., Olguín, V., Rojas-Herrera, M., Heras, M. L., Calderón, J. F., Zanlungo, S., Priestman, D. A., Platt, F. M., & Klein, A. D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101105 · Cited by 9
Neuroimaging and Neuropathological Findings in Bipolar Disorder
Savitz, J. B., & Drevets, W. C. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_68 · Cited by 9
Axonal transport deficits in neuropsychiatric disorders
Badal, K. K., & Puthanveettil, S. V. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103786 · Cited by 8
Acero-Castillo, M. C., Correia, M. B. M., Caixeta, F. V., Motta, V., Barros, M., & Maior, R. S. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110088 · Cited by 8
Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder
Liu, R., Liu, N., Ma, L., Liu, Y., Huang, Z., Peng, X., Zhuang, C., Niu, J., Yu, J., & Du, J. (2024) · CNS Drugs · doi:10.1007/s40263-024-01123-x · Cited by 8
Nour, M. M., Beck, K., Liu, Y., Arumuham, A., Veronese, M., Howes, O. D., & Dolan, R. J. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac044 · Cited by 8
Li, R., Zhao, X., Cai, L., & Gao, W.-W. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.07.024 · Cited by 8
Gil‐Ad, I., Portnoy, M., Tarasenko, I., Bidder, M., Kramer, M., Taler, M., & Weizman, A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.009 · Cited by 8
Partial Rodent Genetic Models for Bipolar Disorder
Chen, G., Henter, I. D., & Manji, H. K. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_63 · Cited by 8
Manev, R. M., Mrazovac, D., & Manev, H. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.02.038 · Cited by 8
Yao, D., Yang, E., Guan, H., Sui, J., Zhang, Z., & Liu, M. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-87240-3_17 · Cited by 7
Beanes, G., Caliman‐Fontes, A. T., Souza‐Marques, B., Silva, H. D. S., Leal, G. C.-G., Carneiro, B. A., Guerreiro‐Costa, L. N. F., Figueiredo, A. V., Figueiredo, C. A., Lacerda, A. L. T., et al. (2022) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000517 · Cited by 7
Kara, N. Z., Flaisher-Grinberg, S., & Einat, H. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.02.008 · Cited by 7
Fasipe, O. J. (2019) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_110_18 · Cited by 7
Beck, K., Arumuham, A., Brugger, S. P., McCutcheon, R. A., Veronese, M., Santangelo, B., McGinnity, C. J., Dunn, J., Kaar, S. J., Singh, N., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221099643 · Cited by 7
Zhang, L., Luo, L., Xue, L., Ran, D., Yang, F. Y., Tang, Q., & Jiang, W. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114299 · Cited by 7
Ionotropic glutamate receptors in GtoPdb v.2023.1
Bettler, B., Collingridge, G. L., Dingledine, R. J., Heinemann, S. F., Hollmann, M., Lerma, J., Lodge, D., Mayer, M. L., Mishina, M., Mulle, C., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f75/2023.1 · Cited by 7
Ma, H., Xun, G., Zhang, R., Yang, X., & Cao, Y. (2019) · Brain and Behavior · doi:10.1002/brb3.1449 · Cited by 7
Correction: Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome
Alves, F. D. S., Boot, E., Schmitz, N., Nederveen, A. J., Vorstman, J. A. S., Lavini, C., Pouwels, P. J. W., de Haan, L., LINSZEN, D. H., & van Amelsvoort, T. (2011) · PLoS ONE · doi:10.1371/annotation/805ba3f5-0fd7-41f9-bc2c-31ebf507f05b · Cited by 7
Announcing the first novel class of rapid-onset antidepressants in clinical practice
Fasipe, O., Akhideno, P., Owhin, O., & Ibiyemi-Fasipe, O. (2019) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_36_19 · Cited by 6
Hu, M., Gao, Y., & El‐Mallakh, R. S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.064 · Cited by 6
Mao, L., Mathur, N., & Wang, J. Q. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.05.007 · Cited by 6
Actualización clínica de la psicosis
Álvarez-Mon, M. A., Vidal, C., & Ortuño, F. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.09.010 · Cited by 6
Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies
Kristiansen, L. V., Cowell, R. M., Biscaia, M., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_14 · Cited by 6
Self-citationSeregin, A., Smirnova, L. P., Dmitrieva, E. M., Васильева, С. Н., Semke, A. V., & Ivanova, S. А. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-3-22-31 · Cited by 6
Rajkowska, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_14 · Cited by 6
Ionotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Bettler, B., Collingridge, G. L., Dingledine, R. J., Heinemann, S. F., Hollmann, M., Lerma, J., Lodge, D., Mayer, M. L., Mishina, M., Mulle, C., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f75/2019.4 · Cited by 6
Gerace, E., Polenzani, L., Magnani, M., Zianni, E., Stocca, G., Gardoni, F., Pellegrini-Giampietro, D. E., & Corradetti, R. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109307 · Cited by 6
Walters, J. M., Noblet, H. A., & Chung, H. J. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106641 · Cited by 5
Plasma Metabolic and Inflammatory Protein Signatures in Psychiatric Disorders
Naifar, M., Ducatez, F., Guidara, W., Maalej, M., Lesueur, C., Pilon, C., Plichet, T., Maalej, M. A., Ayadi, F. M., & Bekri, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136260 · Cited by 5
Taniguchi, K., Kaneko, N., Wada, M., Moriyama, S., Nakajima, S., Mimura, M., & Noda, Y. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12458 · Cited by 5
Biomarkers of Depression: Potential Diagnostic Tools
Perković, M. N., Erjavec, G. N., Štrac, D. Š., & Pivac, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_3 · Cited by 5
Smaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_176 · Cited by 5
Diagnosis of Major Depressive Disorders: Clinical and Biological Perspectives
Fakhoury, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_4 · Cited by 5
Chitty, K. M., Lagopoulos, J., Hickie, I. B., & Hermens, D. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.004 · Cited by 5
Cytoarchitecture cérébrale dans la schizophrénie
Erb, A., & Franck, N. (2009) · PSN · doi:10.1007/s11836-009-0078-2 · Cited by 5
Ganguly, P., Holland, F. H., & Brenhouse, H. C. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.334 · Cited by 5
Uezato, A., Jitoku, D., Shimazu, D., Yamamoto, N., Kurumaji, A., Iwayama, Y., Toyota, T., Yoshikawa, T., Haroutunian, V. H., Bentea, E., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02503-7 · Cited by 4
Self-citationGonadotropin-Dependent Precocious Puberty: Single-Center Experience From Western India
Phadte, A., Sarathi, V., Budyal, S. R., Lila, A. R., Memon, S. S., Karlekar, M. P., Patil, V. A., Shah, N. S., & Bandgar, T. (2023) · Indian Pediatrics · doi:10.1007/s13312-023-2909-y · Cited by 4
Wu, X., Shukla, R., Alganem, K., DePasquale, E. A. K., Reigle, J. K., Simmons, M. S., Hahn, C.-G., Haroutunian, V. H., Meller, J., Meador‐Woodruff, J. H., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.892 · Cited by 4
Self-citationRéus, G. Z., Abelaira, H. M., Coutellier, L. D., Manosso, L. M., & Pavlovic, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_3 · Cited by 4
Astroglia and Severe Mental Illness: A Role for Glutamate Microdomains
McCullumsmith, R. E., Shan, D., Yates, S. D., & Roberts, R. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_16 · Cited by 4
Self-citationNeurotransmitter Systems in Bipolar Disorder
Nakic, M., Krystal, J. H., & Bhagwagar, Z. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch16 · Cited by 4
Neurodegenerative changes in depression: Excitotoxicity or a deficit of trophic factors?
Kudryashova, I. V. (2015) · Neurochemical Journal · doi:10.1134/s1819712415010043 · Cited by 5
Epigenetic Dysregulation in the Schizophrenic Brain
Halene, T. B., Peter, C. J., & Akbarian, S. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0007-0 · Cited by 4
Nitric Oxide Signaling in Depression and Antidepressant Action
Wegener, G., & Joca, S. R. L. (2016) · Springer eBooks · doi:10.1007/978-81-322-2803-5_45 · Cited by 4
Waldman, L., Richardson, B., Hamilton, J., & Thanos, P. K. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136657 · Cited by 4
Genetic and functional investigation of FXYD6 and MAP2K7 as risk factors in schizophrenia
Thompson, R. (2013) · Enlighten: Theses (The University of Glasgow) · Cited by 4
Bastos, T. D. C. D. N. M. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/z00c-4d51 · Cited by 5
Tsugawa, S., Kimura, Y., Chikazoe, J., Abe, H., Arisawa, T., Hatano, M., Nakajima, W., Uchida, H., Miyazaki, T., Takada, Y., et al. (2025) · Frontiers in Neural Circuits · doi:10.3389/fncir.2025.1624179 · Cited by 3
Kryst, J., Chocyk, A., Solarz, A., & Majcher‐Maślanka, I. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00712-x · Cited by 3
Meridianins Inhibit GSK3β In Vivo and Improve Behavioral Alterations Induced by Chronic Stress
Sancho‐Balsells, A., García-García, E., Flotta, F., Chen, W., Alberch, J., Rodríguez, M. J., Àvila, C., & Giralt, A. (2022) · Marine Drugs · doi:10.3390/md20100648 · Cited by 3
Role of Neurotoxicity in Depression
Smaga, I., Krzyżanowska, W., Pomierny, B., Budziszewska, B., Pilc, A., & Nowak, G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_176 · Cited by 3
Oh, D. H., Park, S., Park, Y. C., & Kim, S. H. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00581.x · Cited by 3
Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3
Xu, Y., Du, J., Du, Z.-A., Liu, D.-L., Chen, K., Che, Y., Wu, F., Yu, G., Zhang, W.-B., Zheng, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120634 · Cited by 2
La señalización celular en la esquizofrenia
Amaya, J. M. G. (2009) · Dialnet (Universidad de la Rioja) · Cited by 2
Involvement of the GABA and glutamate neurotransmitter systems in bipolar disorder
Stokes, P. R. A., & Stone, J. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.006 · Cited by 2
Gao, Y., Mack, A. A., Litteral, C. A., Delamere, N. A., & El‐Mallakh, R. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-14187-w · Cited by 2
Posttranslational Histone Modifications and the Neurobiology of Psychosis
Akbarian, S., Cheung, I. K., Connor, C., Jakovcevski, M., & Jiang, Y. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_1 · Cited by 2
Glutamatergic Synaptic Dysregulation in Schizophrenia
Coyle, J. T., Basu, A. C., & Benneyworth, M. A. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch5 · Cited by 2
AMPA Receptor Positive Modulators
Morrow, J. A., Maclean, J. K. F., & Jamieson, C. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch7 · Cited by 2
Epigenetic Approaches to Define the Molecular and Genetic Risk Architectures of Schizophrenia
Kundaković, M., Peter, C. J., Roussos, P., & Akbarian, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00013-6 · Cited by 2
Dysregulation of the Glutamatergic System in Major Depressive Disorder
Cooper, T. M., & Iosifescu, D. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00012-4 · Cited by 2
Schmerder, K., & Freund, N. (2022) · Neuromethods · doi:10.1007/978-1-0716-2748-8_13 · Cited by 2
A Study of Candidate Genes in Depression and Disturbed Sleep
Utge, S. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 2
Characterising the function of ZNF804A: A top genome-wide association study hit for schizophrenia
Chapman, R. M. (2013) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 2
Wu, X., Wang, P., Lang, X., Guo, Q., Jiang, Y., Xu, J., Wang, Q., Kang, Y., Liu, F., Ding, H., et al. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07895-4 · Cited by 1
Lee, T. Y., Eom, K., Kim, J. J., Lee, Y., & Hyun, J. H. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.029 · Cited by 1
Mood and Memory: An Association Between Pattern Separation and Depression
Shelton, D. J. (2013) · ScholarsArchive (Brigham Young University) · Cited by 1
Khundakar, A. A., & Thomas, A. J. (2015) · Advances in Alzheimer's disease · doi:10.3233/978-1-61499-542-5-187 · Cited by 1
Samico, A., Venâncio, Â., & Graça, S. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.25752/psi.8931 · Cited by 1
Smaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_176-1 · Cited by 1
AMPA Receptor Potentiators as Potential Rapid-Acting Antidepressants
Garro-Martínez, E., & Adell, A. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_6 · Cited by 1
Hu, T., Hsu, S.-H., Tsai, H.-Y., & Cheng, M.-C. (2024) · SynBio · doi:10.3390/synbio2010004 · Cited by 1
Aetiopathogenesis of Bipolar Disorder
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_13 · Cited by 1
Plasticity based strategies for the treatment of depression
Apazoglou, K. (2012) · theses.fr (ABES) · doi:10.70675/1ffaa907z696az4218zacbfzac7807473e37 · Cited by 1
Studies of emotionality in genetic mouse models of altered glutamate or 5-HT function
Barkus, C. (2010) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mn2ngxjbw · Cited by 1
Genetic analysis of bipolar disorder and alcohol use disorder
Dalvie, S. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Faye, C. (2019) · theses.fr (ABES) · doi:10.70675/b3ef3280z5adbz4bf3za491zddb2cbdf6aa0 · Cited by 1
Coutens, B. (2022) · theses.fr (ABES) · doi:10.70675/7ffbfd7ezefb5z4e4ez82f4z42a6ac0ff754 · Cited by 1
Regulation and Pharmacological Manipulation of the Type 5 Metabotropic Glutamate (mGlu5) Receptor
Bradley, S. J. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Bosaipo, N. B. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2012.tde-18092012-162629
Zoller, V. (2015) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.18175
Bipolar disorder and cognitive functioning : a two-year naturalistic study
Arts, B. M. G. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120511ba
Der Einfluss von NMDA-Rezeptoruntereinheiten auf synaptische Plastizität in der lateralen Amygdala
Müller, T. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5424
22q11 Deletion syndrome and neurotransmitter systems in unchallenged and challenged conditions
Boot, H. (2010) · UvA-DARE (University of Amsterdam)
Levels of Ionotropic Glutamate and Muscarinic Receptors in Three Animal Models of Schizophrenia
Dean, B. (2011) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523801104010025
Björkholm, C. (2013) · Figshare
Human neuropsin 遺伝子と精神疾患・認知機能との関連
泉, 愛. (2009) · Institutional Repositories DataBase (IRDB) · doi:10.34413/dr.00838
Metadata
- Authors
- Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-14
- Volume
- 32
- Issue
- 9
- Pages
- 1888-1902
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2024278554
- Cited by
- 408
- References
- 115
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 32 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 10 · 2017: 13 · 2016: 18 · 2015: 32 · 2014: 23 · 2013: 25 · 2012: 28
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute
- National Institute of Mental Health (MH 53327, R01MH053327)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- glutamate receptors, schizophrenia, bipolar disorder, major depressive disorder, mood disorders, medial temporal lobe, entorhinal cortex, perirhinal cortex, hippocampus, NMDA receptor, AMPA receptors, kainate receptors, receptor binding, glutamatergic neurotransmission, synaptic transmission
- MeSH terms
- Adult, Analysis of Variance, Autoradiography, Female, Gene Expression Regulation, Humans, Indoles, Male, Middle Aged, Postmortem Changes, Protein Binding, Schizophrenia, Temporal Lobe, 2-Amino-5-phosphonovalerate, In Situ Hybridization, Receptors, Glutamate, Excitatory Amino Acid Antagonists, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.